Variant Bio, a genomics-driven drug discovery company, today announced a multi-year research collaboration with Novo Nordisk to discover novel targets for the treatment of metabolic disease.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...